High-dose Low-dose Prednisolone in Symptomatic Patients with Post-COVID-19 Diffuse Parenchymal Lung Abnormalities: an Open-label, Randomised Trial (the COLDSTER Trial)

Overview

Journal Eur Respir J

Specialty Pulmonary Medicine

Date 2021 Dec 10

PMID 34887325

Citations 22

Authors

Sahajal Dhooria

Shivani Chaudhary

Inderpaul Singh Sehgal

Ritesh Agarwal

Siddhant Arora

Mandeep Garg

Nidhi Prabhakar

Goverdhan Dutt Puri

Ashish Bhalla

Vikas Suri

Lakshmi Narayana Yaddanapudi

Valliappan Muthu

Kuruswamy Thurai Prasad

Ashutosh Nath Aggarwal

Affiliations

Soon will be listed here.

Citing Articles

Long-Term Lung Sequelae in Survivors of Severe/Critical COVID-19 Pneumonia: The "Non-Steroid", "Non-Interventional" Approach.

Antonogiannaki E, Grigoropoulos I, Manali E, Thomas K, Kallieri M, Alexopoulou P J Clin Med. 2025; 14(2.

PMID: 39860353 PMC: 11766020. DOI: 10.3390/jcm14020347.

Trans-bronchial forceps biopsy for COVID-19 related diffuse parenchymal lung abnormalities.

Kleymann J, Bruckmann S, Langner S, Koschel D, Kolditz M BMC Pulm Med. 2024; 24(1):631.

PMID: 39716184 PMC: 11667939. DOI: 10.1186/s12890-024-03449-0.

Multidisciplinary Management Strategies for Long COVID: A Narrative Review.

Prusinski C, Yan D, Klasova J, McVeigh K, Shah S, Fermo O Cureus. 2024; 16(5):e59478.

PMID: 38826995 PMC: 11142761. DOI: 10.7759/cureus.59478.

The effectiveness of glucocorticoid treatment in post-COVID-19 pulmonary involvement.

Mizera J, Genzor S, Sova M, Stanke L, Burget R, Jakubec P Pneumonia (Nathan). 2024; 16(1):2.

PMID: 38311783 PMC: 10840187. DOI: 10.1186/s41479-023-00123-7.

The clinical, functional, and radiological effect of long-term used immunosuppressive therapy for post-COVID-19 interstitial lung disease.

Gul S, Demirkol B, Eren R, Baydili K, Babaoglu Elkhatroushi B, Ulusan S Sarcoidosis Vasc Diffuse Lung Dis. 2023; 40(4):e2023049.

PMID: 38126500 PMC: 10965009. DOI: 10.36141/svdld.v40i4.15055.

References

Segala F, Sgalla G, Salvati F, Berardini L, Negri M, Nardella E . Adjunctive corticosteroid treatment for organizing pneumonia in COVID-19 patients with persistent respiratory failure. Respir Med. 2021; 187:106571. PMC: 8352674. DOI: 10.1016/j.rmed.2021.106571. View

Sinha R, van den Heuvel W, Arokiasamy P . Validity and Reliability of MOS Short Form Health Survey (SF-36) for Use in India. Indian J Community Med. 2013; 38(1):22-6. PMC: 3612292. DOI: 10.4103/0970-0218.106623. View

Patel A, Siegert R, Brignall K, Gordon P, Steer S, Desai S . The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire. Thorax. 2012; 67(9):804-10. DOI: 10.1136/thoraxjnl-2012-201581. View

Funke-Chambour M, Bridevaux P, Clarenbach C, Soccal P, Nicod L, von Garnier C . Swiss Recommendations for the Follow-Up and Treatment of Pulmonary Long COVID. Respiration. 2021; 100(8):826-841. PMC: 8339046. DOI: 10.1159/000517255. View

Montani D, Savale L, Beurnier A, Colle R, Noel N, Pham T . Multidisciplinary approach for post-acute COVID-19 syndrome: time to break down the walls. Eur Respir J. 2021; 58(1). PMC: 8112007. DOI: 10.1183/13993003.01090-2021. View

Miller M, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A . Standardisation of spirometry. Eur Respir J. 2005; 26(2):319-38. DOI: 10.1183/09031936.05.00034805. View

Petitpierre N, Cottin V, Marchand-Adam S, Hirschi S, Rigaud D, Court-Fortune I . A 12-week combination of clarithromycin and prednisone compared to a 24-week prednisone alone treatment in cryptogenic and radiation-induced organizing pneumonia. Sarcoidosis Vasc Diffuse Lung Dis. 2020; 35(3):230-238. PMC: 7170161. DOI: 10.36141/svdld.v35i3.6547. View

Gonzalez J, Benitez I, Carmona P, Santisteve S, Monge A, Moncusi-Moix A . Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19: A 3-Month Prospective Cohort. Chest. 2021; 160(1):187-198. PMC: 7930807. DOI: 10.1016/j.chest.2021.02.062. View

Garg M, Maralakunte M, Garg S, Dhooria S, Sehgal I, Bhalla A . The Conundrum of 'Long-COVID-19': A Narrative Review. Int J Gen Med. 2021; 14:2491-2506. PMC: 8214209. DOI: 10.2147/IJGM.S316708. View

10.

Holland A, Spruit M, Troosters T, Puhan M, Pepin V, Saey D . An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014; 44(6):1428-46. DOI: 10.1183/09031936.00150314. View

11.

Kostorz-Nosal S, Jastrzebski D, Chyra M, Kubicki P, Zielinski M, Ziora D . A prolonged steroid therapy may be beneficial in some patients after the COVID-19 pneumonia. Eur Clin Respir J. 2021; 8(1):1945186. PMC: 8231404. DOI: 10.1080/20018525.2021.1945186. View

12.

Myall K, Mukherjee B, Castanheira A, Lam J, Benedetti G, Mak S . Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment. Ann Am Thorac Soc. 2021; 18(5):799-806. PMC: 8086530. DOI: 10.1513/AnnalsATS.202008-1002OC. View

13.

Hinchcliff M, Beaumont J, Thavarajah K, Varga J, Chung A, Podlusky S . Validity of two new patient-reported outcome measures in systemic sclerosis: Patient-Reported Outcomes Measurement Information System 29-item Health Profile and Functional Assessment of Chronic Illness Therapy-Dyspnea short form. Arthritis Care Res (Hoboken). 2011; 63(11):1620-8. PMC: 3205420. DOI: 10.1002/acr.20591. View

14.

Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q . 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. 2021; 9(7):747-754. PMC: 8099316. DOI: 10.1016/S2213-2600(21)00174-0. View

15.

Shah A, Wong A, Hague C, Murphy D, Johnston J, Ryerson C . A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations. Thorax. 2020; 76(4):402-404. DOI: 10.1136/thoraxjnl-2020-216308. View